This list is an analysis based on recent market events. It's not an investment recommendation.
About
Oncimmune Holdings plc, a precision medicine company, provides autoantibody biomarker profiling in immuno-oncology, autoimmune, and infectious diseases in Europe and internationally. The company offers ImmunoINSIGHTS platform, an autoantibody profiling service that provides insights to discover and validate novel biomarkers, validate drug mode of action, improve treatment responses and adverse event (irAE) prediction, patient screening, and diagnostic accuracy; Sero Tag, a discovery engine for the identification of relevant biomarker pool for target discovery or companion diagnostics; NavigAID for creation of a disease-specific biomarker panel; and Autoantibody Biomarkers, a companion diagnostic biomarker. It also provides business development and marketing services. Oncimmune Holdings plc was incorporated in 2015 and is headquartered in Leeds, the United Kingdom.
The current price of OCY.F is €0.01 EUR — it has decreased by -18.52% in the past 24 hours. Watch Oncimmune stock price performance more closely on the chart.
What is Oncimmune stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Oncimmune stocks are traded under the ticker OCY.F.
What is Oncimmune revenue for the last year?▼
Oncimmune revenue for the last year amounts to 4.64M EUR.
What is Oncimmune net income for the last year?▼
OCY.F net income for the last year is -5.59M EUR.
How many employees does Oncimmune have?▼
As of September 07, 2026, the company has 40 employees.
In which sector is Oncimmune located?▼
Oncimmune operates in the Other sector.
When did Oncimmune complete a stock split?▼
Oncimmune has not had any recent stock splits.
Where is Oncimmune headquartered?▼
Oncimmune is headquartered in Leeds, United Kingdom.